ID   CREB1_RAT               Reviewed;         327 AA.
AC   P15337;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   07-OCT-2020, sequence version 2.
DT   02-OCT-2024, entry version 222.
DE   RecName: Full=Cyclic AMP-responsive element-binding protein 1;
DE            Short=CREB-1;
DE            Short=cAMP-responsive element-binding protein 1;
GN   Name=Creb1; Synonyms=Creb-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2521922; DOI=10.1038/337749a0;
RA   Gonzalez G.A., Yamamoto K.K., Fischer W.H., Karr D., Menzel P.,
RA   Biggs W. III, Vale W.W., Montminy M.R.;
RT   "A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear
RT   factor CREB predicted by its sequence.";
RL   Nature 337:749-752(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1831258; DOI=10.1093/nar/19.15.4290;
RA   Short M.L., Manohar C.F., Furtado M.R., Ghadge G.D., Wolinsky S.M.,
RA   Thimmapaya B., Jungmann R.A.;
RT   "Nucleotide and derived amino-acid sequences of the CRE-binding proteins
RT   from rat C6 glioma and HeLa cells.";
RL   Nucleic Acids Res. 19:4290-4290(1991).
RN   [3]
RP   PHOSPHORYLATION AT SER-119, AND PHOSPHORYLATION BY CAMK1 AND CAMK4.
RX   PubMed=1646483; DOI=10.1126/science.1646483;
RA   Sheng M., Thompson M.A., Greenberg M.E.;
RT   "CREB: a Ca(2+)-regulated transcription factor phosphorylated by
RT   calmodulin-dependent kinases.";
RL   Science 252:1427-1430(1991).
RN   [4]
RP   PHOSPHORYLATION AT SER-119 AND SER-128, AND MUTAGENESIS OF SER-119 AND
RP   SER-128.
RX   PubMed=7958915; DOI=10.1101/gad.8.21.2527;
RA   Sun P., Enslen H., Myung P.S., Maurer R.A.;
RT   "Differential activation of CREB by Ca2+/calmodulin-dependent protein
RT   kinases type II and type IV involves phosphorylation of a site that
RT   negatively regulates activity.";
RL   Genes Dev. 8:2527-2539(1994).
RN   [5]
RP   PHOSPHORYLATION AT SER-119, AND PHOSPHORYLATION BY CAMK1.
RX   PubMed=8621702; DOI=10.1074/jbc.271.6.3066;
RA   Sun P., Lou L., Maurer R.A.;
RT   "Regulation of activating transcription factor-1 and the cAMP response
RT   element-binding protein by Ca2+/calmodulin-dependent protein kinases type
RT   I, II, and IV.";
RL   J. Biol. Chem. 271:3066-3073(1996).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   FUNCTION.
RX   PubMed=30566056; DOI=10.1161/circresaha.118.313777;
RA   Otaka N., Shibata R., Ohashi K., Uemura Y., Kambara T., Enomoto T.,
RA   Ogawa H., Ito M., Kawanishi H., Maruyama S., Joki Y., Fujikawa Y.,
RA   Narita S., Unno K., Kawamoto Y., Murate T., Murohara T., Ouchi N.;
RT   "Myonectin Is an Exercise-Induced Myokine That Protects the Heart From
RT   Ischemia-Reperfusion Injury.";
RL   Circ. Res. 123:1326-1338(2018).
RN   [8]
RP   STRUCTURE BY NMR OF 105-132 IN COMPLEX WITH CREBBP.
RX   PubMed=10222196; DOI=10.1006/jmbi.1999.2658;
RA   Radhakrishnan I., Perez-Alvarado G.C., Parker D., Dyson H.J.,
RA   Montminy M.R., Wright P.E.;
RT   "Structural analyses of CREB-CBP transcriptional activator-coactivator
RT   complexes by NMR spectroscopy: implications for mapping the boundaries of
RT   structural domains.";
RL   J. Mol. Biol. 287:859-865(1999).
CC   -!- FUNCTION: Phosphorylation-dependent transcription factor that
CC       stimulates transcription upon binding to the DNA cAMP response element
CC       (CRE), a sequence present in many viral and cellular promoters (By
CC       similarity). Transcription activation is enhanced by the TORC
CC       coactivators which act independently of Ser-119 phosphorylation (By
CC       similarity). Involved in different cellular processes including the
CC       synchronization of circadian rhythmicity and the differentiation of
CC       adipose cells (By similarity). Regulates the expression of apoptotic
CC       and inflammatory response factors in cardiomyocytes in response to
CC       ERFE-mediated activation of AKT signaling (PubMed:30566056).
CC       {ECO:0000250|UniProtKB:P16220, ECO:0000250|UniProtKB:P27925,
CC       ECO:0000250|UniProtKB:Q01147, ECO:0000269|PubMed:30566056}.
CC   -!- SUBUNIT: Interacts with PPRC1. Binds DNA as a dimer. This dimer is
CC       stabilized by magnesium ions. Interacts, through the bZIP domain, with
CC       the coactivators CRTC1/TORC1, CRTC2/TORC2 and CRTC3/TORC3. When
CC       phosphorylated on Ser-119, binds CREBBP (By similarity). Interacts with
CC       CREBL2; regulates CREB1 phosphorylation, stability and transcriptional
CC       activity (By similarity). Interacts (phosphorylated form) with TOX3.
CC       Interacts with ARRB1. Binds to HIPK2. Interacts with SGK1. Interacts
CC       with TSSK4; this interaction facilitates phosphorylation on Ser-119.
CC       Forms a complex with KMT2A and CREBBP (By similarity). Interacts with
CC       TOX4; CREB1 is required for full induction of TOX4-dependent activity
CC       and the interaction is increased by cAMP and inhibited by insulin (By
CC       similarity). {ECO:0000250|UniProtKB:P16220,
CC       ECO:0000250|UniProtKB:Q01147}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Delta;
CC         IsoId=P15337-2; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=P15337-1; Sequence=VSP_060705;
CC   -!- PTM: Phosphorylation of Ser-119 allows CREBBP binding. Stimulated by
CC       phosphorylation. Phosphorylation of both Ser-128 and Ser-119 in the SCN
CC       regulates the activity of CREB and participate in circadian rhythm
CC       generation (By similarity). Phosphorylated upon calcium influx by CaMK4
CC       and CaMK2 on Ser-119. CaMK4 is much more potent than CaMK2 in
CC       activating CREB. Phosphorylated by CaMK2 on Ser-128. Phosphorylation of
CC       Ser-128 blocks CREB-mediated transcription even when Ser-119 is
CC       phosphorylated. Phosphorylated by CaMK1. Phosphorylation of Ser-257 by
CC       HIPK2 in response to genotoxic stress promotes CREB1 activity,
CC       facilitating the recruitment of the coactivator CBP. Phosphorylated at
CC       Ser-119 by RPS6KA3, RPS6KA4 and RPS6KA5 in response to mitogenic or
CC       stress stimuli (By similarity). CREBL2 positively regulates
CC       phosphorylation at Ser-119 thereby stimulating CREB1 transcriptional
CC       activity. In liver, phosphorylation is induced by fasting or glucagon
CC       in a circadian fashion (By similarity). Phosphorylated by TSSK4 on Ser-
CC       119 (By similarity). {ECO:0000250|UniProtKB:P16220}.
CC   -!- PTM: Sumoylated with SUMO1. Sumoylation on Lys-290, but not on Lys-271,
CC       is required for nuclear localization of this protein. Sumoylation is
CC       enhanced under hypoxia, promoting nuclear localization and
CC       stabilization (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the bZIP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14788; CAA32890.1; -; mRNA.
DR   EMBL; X60002; CAA42619.1; -; mRNA.
DR   PIR; A35663; A35663.
DR   PIR; S03343; S03343.
DR   PIR; S22299; S22299.
DR   RefSeq; NP_112279.1; NM_031017.1. [P15337-1]
DR   RefSeq; NP_604392.1; NM_134443.1. [P15337-2]
DR   RefSeq; XP_006245127.1; XM_006245065.3.
DR   RefSeq; XP_006245128.1; XM_006245066.3.
DR   PDB; 1KDX; NMR; -; B=105-132.
DR   PDBsum; 1KDX; -.
DR   AlphaFoldDB; P15337; -.
DR   BMRB; P15337; -.
DR   SMR; P15337; -.
DR   BioGRID; 249546; 3.
DR   DIP; DIP-36407N; -.
DR   IntAct; P15337; 3.
DR   MINT; P15337; -.
DR   STRING; 10116.ENSRNOP00000018326; -.
DR   GlyGen; P15337; 4 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; P15337; -.
DR   PhosphoSitePlus; P15337; -.
DR   PaxDb; 10116-ENSRNOP00000018326; -.
DR   ABCD; P15337; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000018326.6; ENSRNOP00000018326.1; ENSRNOG00000013412.8. [P15337-1]
DR   Ensembl; ENSRNOT00055038699; ENSRNOP00055031423; ENSRNOG00055022525. [P15337-2]
DR   Ensembl; ENSRNOT00060032877; ENSRNOP00060026876; ENSRNOG00060018985. [P15337-2]
DR   Ensembl; ENSRNOT00065046001; ENSRNOP00065037747; ENSRNOG00065026624. [P15337-2]
DR   GeneID; 81646; -.
DR   KEGG; rno:81646; -.
DR   UCSC; RGD:620218; rat. [P15337-2]
DR   AGR; RGD:620218; -.
DR   CTD; 1385; -.
DR   RGD; 620218; Creb1.
DR   VEuPathDB; HostDB:ENSRNOG00000013412; -.
DR   eggNOG; KOG3584; Eukaryota.
DR   GeneTree; ENSGT00940000155408; -.
DR   HOGENOM; CLU_042675_0_1_1; -.
DR   InParanoid; P15337; -.
DR   OMA; QXISTIA; -.
DR   OrthoDB; 3137625at2759; -.
DR   PhylomeDB; P15337; -.
DR   TreeFam; TF106464; -.
DR   Reactome; R-RNO-198693; AKT phosphorylates targets in the nucleus. [P15337-1]
DR   Reactome; R-RNO-199920; CREB phosphorylation. [P15337-1]
DR   Reactome; R-RNO-375165; NCAM signaling for neurite out-growth. [P15337-1]
DR   Reactome; R-RNO-442742; CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling. [P15337-1]
DR   Reactome; R-RNO-881907; Gastrin-CREB signalling pathway via PKC and MAPK. [P15337-1]
DR   Reactome; R-RNO-9031628; NGF-stimulated transcription. [P15337-1]
DR   Reactome; R-RNO-9634638; Estrogen-dependent nuclear events downstream of ESR-membrane signaling. [P15337-1]
DR   EvolutionaryTrace; P15337; -.
DR   PRO; PR:P15337; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000013412; Expressed in testis and 18 other cell types or tissues.
DR   GO; GO:1990589; C:ATF4-CREB1 transcription factor complex; ISO:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0000785; C:chromatin; IDA:BHF-UCL.
DR   GO; GO:0000791; C:euchromatin; ISO:RGD.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:RGD.
DR   GO; GO:1990763; F:arrestin family protein binding; IPI:RGD.
DR   GO; GO:0035497; F:cAMP response element binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0035035; F:histone acetyltransferase binding; IPI:RGD.
DR   GO; GO:0030544; F:Hsp70 protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; IPI:CAFA.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IMP:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEP:RGD.
DR   GO; GO:1904322; P:cellular response to forskolin; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISO:RGD.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; ISO:RGD.
DR   GO; GO:1990314; P:cellular response to insulin-like growth factor stimulus; IEP:RGD.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0071294; P:cellular response to zinc ion; ISO:RGD.
DR   GO; GO:0034670; P:chemotaxis to arachidonic acid; IMP:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0046879; P:hormone secretion; ISO:RGD.
DR   GO; GO:0007595; P:lactation; ISO:RGD.
DR   GO; GO:0060428; P:lung epithelium development; ISO:RGD.
DR   GO; GO:0060430; P:lung saccule development; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0007613; P:memory; IMP:RGD.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; ISO:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:RGD.
DR   GO; GO:0021983; P:pituitary gland development; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0055025; P:positive regulation of cardiac muscle tissue development; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0046887; P:positive regulation of hormone secretion; ISO:RGD.
DR   GO; GO:0046889; P:positive regulation of lipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:1904181; P:positive regulation of membrane depolarization; IMP:RGD.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0045899; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0032916; P:positive regulation of transforming growth factor beta3 production; IMP:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0008361; P:regulation of cell size; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0048145; P:regulation of fibroblast proliferation; IMP:RGD.
DR   GO; GO:0060251; P:regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:2000224; P:regulation of testosterone biosynthetic process; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:1903494; P:response to dehydroepiandrosterone; IEP:RGD.
DR   GO; GO:0036017; P:response to erythropoietin; IDA:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0033762; P:response to glucagon; ISS:UniProtKB.
DR   GO; GO:1990910; P:response to hypobaric hypoxia; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:1902065; P:response to L-glutamate; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014074; P:response to purine-containing compound; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0033363; P:secretory granule organization; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:RGD.
DR   GO; GO:0060509; P:type I pneumocyte differentiation; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; IMP:RGD.
DR   CDD; cd14690; bZIP_CREB1; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   IDEAL; IID50004; -.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR003102; CREB1-like_pKID.
DR   InterPro; IPR001630; Leuzip_CREB.
DR   PANTHER; PTHR45879; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN B; 1.
DR   PANTHER; PTHR45879:SF1; CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN 1; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   Pfam; PF02173; pKID; 1.
DR   PRINTS; PR00041; LEUZIPPRCREB.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
DR   PROSITE; PS50953; KID; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Biological rhythms;
KW   Differentiation; Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..327
FT                   /note="Cyclic AMP-responsive element-binding protein 1"
FT                   /id="PRO_0000076599"
FT   DOMAIN          8..146
FT                   /note="KID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00312"
FT   DOMAIN          269..327
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          94..113
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          126..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          270..295
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          297..318
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   MOD_RES         119
FT                   /note="Phosphoserine; by CaMK1, CaMK2, CaMK4, PKB/AKT1 or
FT                   PKB/AKT2, RPS6KA3, RPS6KA4, RPS6KA5 and SGK1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00312,
FT                   ECO:0000269|PubMed:1646483, ECO:0000269|PubMed:7958915,
FT                   ECO:0000269|PubMed:8621702"
FT   MOD_RES         128
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00312,
FT                   ECO:0000269|PubMed:7958915, ECO:0007744|PubMed:22673903"
FT   MOD_RES         257
FT                   /note="Phosphoserine; by HIPK2"
FT                   /evidence="ECO:0000250|UniProtKB:P16220,
FT                   ECO:0000255|PROSITE-ProRule:PRU00312"
FT   CROSSLNK        122
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P16220"
FT   CROSSLNK        271
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P16220"
FT   CROSSLNK        290
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P16220"
FT   VAR_SEQ         86
FT                   /note="V -> VQSSCKDLKRLFSGT (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060705"
FT   MUTAGEN         119
FT                   /note="S->A: Loss of activation by CaMK4."
FT                   /evidence="ECO:0000269|PubMed:7958915"
FT   MUTAGEN         128
FT                   /note="S->A: Loss of phosphorylation by CaMK2. Activation
FT                   by CaMK2."
FT                   /evidence="ECO:0000269|PubMed:7958915"
FT   CONFLICT        121
FT                   /note="R -> K (in Ref. 2; CAA42619)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305
FT                   /note="E -> K (in Ref. 2; CAA42619)"
FT                   /evidence="ECO:0000305"
FT   HELIX           106..114
FT                   /evidence="ECO:0007829|PDB:1KDX"
FT   HELIX           119..130
FT                   /evidence="ECO:0007829|PDB:1KDX"
SQ   SEQUENCE   327 AA;  35081 MW;  D6D715DEED679FF2 CRC64;
     MTMDSGADNQ QSGDAAVTEA ESQQMTVQAQ PQIATLAQVS MPAAHATSSA PTVTLVQLPN
     GQTVQVHGVI QAAQPSVIQS PQVQTVQIST IAESEDSQES VDSVTDSQKR REILSRRPSY
     RKILNDLSSD APGVPRIEEE KSEEETSAPA ITTVTVPTPI YQTSSGQYIA ITQGGAIQLA
     NNGTDGVQGL QTLTMTNAAA TQPGTTILQY AQTTDGQQIL VPSNQVVVQA ASGDVQTYQI
     RTAPTSTIAP GVVMASSPAL PTQPAEEAAR KREVRLMKNR EAARECRRKK KEYVKCLENR
     VAVLENQNKT LIEELKALKD LYCHKSD
//
